Evidence map›Paper›PMID 32971821›Full record

ArticleJournal of clinical medicine2020

Monomeric C-Reactive Protein Aggravates Secondary Degeneration after Intracerebral Haemorrhagic Stroke and May Function as a Sensor for Systemic Inflammation.

Mark Slevin, Elisa García-Lara, Bogdan Capitanescu, Coral Sanfeliu, Yasmin Zeinolabediny, Raid AlBaradie, Peter Olah, Baoqiang Guo, Daniel Pirici, Mario Di Napoli and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Mark SlevinDepartment of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester M15 6BH, UK.
Elisa García-LaraInstitut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, IDIBAPS and CIBERESP, 08036 Barcelona, Spain.
Bogdan CapitanescuDepartment of Anatomy, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
Coral SanfeliuInstitut d'Investigacions Biomèdiques de Barcelona (IIBB), CSIC, IDIBAPS and CIBERESP, 08036 Barcelona, Spain.
Yasmin ZeinolabedinyDepartment of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester M15 6BH, UK.
Raid AlBaradieApplied Medical Sciences College, Majmaah University, Al Majma'ah 15361, Saudi Arabia.
Peter OlahThe University of Medicine, Pharmacy, Science and Technology at Targu Mures, 540142 Targu Mures, Romania.
Baoqiang GuoRegenesol LTD, Number 30 the Green Building, 19 New Wakefield Street, Manchester M1 5NP, UK.
Daniel PiriciDepartment of Research Methodology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
Mario Di NapoliDepartment of Neurology and Stroke Unit, San Camillo de' Lellis General Hospital, 02100 Rieti, Italy.ORCID 0000-0001-9609-4926
Aurel Popa-WagnerCenter of Eexperimental and Clinical Medicine, University of Medicine and Pharmacy, 200349 Craiova, Romania.ORCID 0000-0003-4574-8605
Centro de Investigación Biomédica en Red · ESManchester Metropolitan University · GBUniversity of Medicine and Pharmacy of Craiova · ROGriffith University · AUMajmaah University · SAUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO

Funding

Spanish Ministry of Science and Innovation SAF2016-77703UEFISCDI PN-III-P4-ID-PCE-2016-0215
6 · The paper itself

Abstract

backgroundWe previously identified increased tissue localization of monomeric C-reactive protein (mCRP) in the infarcted cortical brain tissue of patients following ischaemic stroke. Here, we investigated the relationship of mCRP expression in haemorrhagic stroke, and additionally examined the capacity of mCRP to travel to or appear at other locations within the brain that might account for later chronic neuroinflammatory or neurodegenerative effects.

methodsImmunohistochemistry was performed on Formalin-fixed, paraffin-embedded archived brain tissue blocks obtained at autopsy from stroke patients and age-matched controls. We modelled mCRP migration into the brain after haemorrhagic stroke by infusing mCRP (3.5 µg) into the hippocampus of mice and localized mCRP with histological and immunohistochemistry methods.

resultsOn human tissue in the early stages of haemorrhage, there was no staining of mCRP. However, with increasing post-stroke survival time, mCRP immunostaining was associated with some parenchymal brain cells, some stroke-affected neurons in the surrounding areas and the lumen of large blood vessels as well as brain capillaries. Further from the peri-haematoma region, however, mCRP was detected in the lumen of micro-vessels expressing aquaporin 4 (AQP4). In the hypothalamus, we detected clusters of neurons loaded with mCRP along with scattered lipofuscin-like deposits. In the peri-haematoma region of patients, mCRP was abundantly seen adjacent to AQP4 immunoreactivity. When we stereotactically injected mCRP into the hippocampus of mice, we also observed strong expression in distant neurones of the hypothalamus as well as cortical capillaries.

conclusionsmCRP is abundantly expressed in the brain after haemorrhagic stroke, directly impacting the pathophysiological development of the haematoma. In addition, it may have indirect effects, where the microcirculatory system appears to be able to carry it throughout the cortex as far as the hypothalamus, allowing for long-distance effects and damage through its capacity to induce inflammation and degenerate neuronal perivascular compartments.

Indexed as

haemorrhagic strokehypothalamusmCRPmicro-circulatory systemneuroinflammation

Identifiers

PMID32971821
PMCPMC7563733
OpenAlexW3088289510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.